deltatrials
Completed OBSERVATIONAL NCT01412554

Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up (INFO)

Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow-up

Sponsor: Oslo University Hospital

Updated 13 times since 2017 Last updated: Sep 20, 2019 Started: Aug 31, 2011 Primary completion: Mar 31, 2014 Completion: Mar 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes Mellitus and Hypertension, this trial is completed. The trial is conducted by Oslo University Hospital and has accumulated 13 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2019 · 17 months · monthly snapshot~Nov 2019 – ~Nov 2020 · 12 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

13 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2023 — Jul 2024 [monthly]

    Completed

  4. Dec 2022 — Jan 2023 [monthly]

    Completed

  5. Dec 2021 — Dec 2022 [monthly]

    Completed

Show 8 earlier versions
  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Nov 2019 — Nov 2020 [monthly]

    Completed

  4. Jun 2018 — Nov 2019 [monthly]

    Completed

  5. May 2018 — Jun 2018 [monthly]

    Completed

  6. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  7. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  8. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oslo University Hospital
Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations